The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes
Open accessAbstract
Liver X receptors (LXRs) are nuclear receptors previously identified to be important in lipid metabolism. Recent reports suggest that LXR agonists also exhibit anti-inflammatory properties in mouse models of atherosclerosis and contact dermatitis. In the present study, we investigated the effects of LXR agonists on mouse microglia and astrocytes. When chronically activated, these resident-CNS glia have been implicated in the pathology of neuroinflammatory disorders including multiple sclerosis (MS). Our studies demonstrated for the first time that LXR agonists inhibited the production of nitric oxide, the pro-inflammatory cytokines IL-1beta and IL-6 and the chemokine MCP-1 from LPS-stimulated microglia and astrocytes. Furthermore, LXR agonists inhibited LPS-induction of nuclear factor-kappa B (NF-kappaB) DNA-binding activity. These agonists also blocked LPS-induction of IkappaB-alpha protein degradation in microglia, suggesting a mechanism by which these agonists modulate NF-kappaB DNA-binding activity. These studies suggest that LXR agonists suppress the production of pro-inflammatory molecules by CNS glia, at least in part, by modulating NF-kappaB-signaling pathways. Retinoid X receptors (RXRs) physically interact with LXR receptors, and the resulting obligate heterodimer regulates the expression of LXR-responsive genes. Interestingly, a combination of LXR and RXR agonists additively suppressed the production of NO by microglia and astrocytes. Collectively, these studies suggest that LXR agonists may be effective in the treatment of neuroinflammatory diseases including MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In murine models of AD and neuroinflammation, studies of the effects of nuclear receptor agonists have been focused principally on their actions in astrocytes and microglia5678.”
From Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease (2017) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
McCarthy, K. D., & de Vellis, J. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.85.3.890 · Cited by 3,845
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G. J., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 966
Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., & Mangelsdorf, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.266 · Cited by 946
Li, A. C., Brown, K. K., Silvestre, M., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 836
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W. G., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 769
Cited by
Sorted by citations
Integration of metabolism and inflammation by lipid-activated nuclear receptors
Bensinger, S. J., & Tontonoz, P. (2008) · Nature · doi:10.1038/nature07202 · Cited by 827
Liver X receptors in lipid metabolism: opportunities for drug discovery
Hong, C., & Tontonoz, P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4280 · Cited by 587
Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
Jakobsson, T., Treuter, E., Gustafsson, J.-Å., & Steffensen, K. R. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.013 · Cited by 302
Retinoid X receptors: common heterodimerization partners with distinct functions
Lefèbvre, P., Benomar, Y., & Staels, B. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.009 · Cited by 320
Cytokine Signaling Modulates Blood-Brain Barrier Function
Pan, W., P. Stone, K., Hsuchou, H., K. Manda, V., Zhang, Y., & J. Kastin, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798220918 · Cited by 241
Nutrition Facts in Multiple Sclerosis
Riccio, P., & Rossano, R. (2015) · ASN NEURO · doi:10.1177/1759091414568185 · Cited by 247
Circadian dysfunction in disease
Bechtold, D. A., Gibbs, J. E., & Loudon, A. S. I. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.01.002 · Cited by 213
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
Bilotta, M. T., Petillo, S., Santoni, A., & Cippitelli, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584303 · Cited by 180
Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia
Freilich, R. W., Woodbury, M. E., & Ikezu, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079416 · Cited by 160
Regulation of microglia activation and deactivation by nuclear receptors
Saijo, K., Crotti, A., & Glass, C. K. (2012) · Glia · doi:10.1002/glia.22423 · Cited by 154
Retinoid X receptors in macrophage biology
Rőszer, T., Menéndez-Gutiérrez, M. P., Cedenilla, M., & Ricote, M. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.04.004 · Cited by 137
Morales, J. R., Ballesteros, I., Deniz, J. M., Hurtado, O., Vivancos, J., Nombela, F., Lizasoaín, I., Castrillo, A., & Moro, M. Á. (2008) · Circulation · doi:10.1161/circulationaha.108.782300 · Cited by 117
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 117
Mast, N., Saadane, A., Valencia‐Olvera, A. C., Constans, J., Maxfield, E., Arakawa, H., Li, Y., Landreth, G. E., & Pikuleva, I. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.026 · Cited by 111
Sharma, S., Shen, T., Chitranshi, N., Gupta, V., Basavarajappa, D. K., Sarkar, S., Mirzaei, M., You, Y., Krężel, W., Graham, S. L., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02709-y · Cited by 108
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
Mariani, M. M., Malm, T., Lamb, R., Jay, T. R., Neilson, L., Casali, B., Medarametla, L., & Landreth, G. E. (2017) · Scientific Reports · doi:10.1038/srep42270 · Cited by 98
Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease
Dai, Y.-B., Tan, X.-J., Wu, W.-F., Warner, M. N., & Gustafsson, J.-Α. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210833109 · Cited by 104
Fan, J., Liu, D., Huang, G., Xu, Z., Jia, Y., Zhang, H., Li, X., & He, F. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.05.053 · Cited by 96
Nuclear receptors in neurodegenerative diseases
Skerrett, R., Malm, T., & Landreth, G. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.019 · Cited by 94
Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases
Xu, P., Li, D., Tang, X., Bao, X., Huang, J., Tang, Y., Yang, Y., Xu, H., & Fan, X. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84
Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity
Xu, J., Wagoner, G., Douglas, J. C., & Drew, P. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008600 · Cited by 83
Self-citationRegulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
Mouzat, K., Chudinova, A., Polge, A. S., Kantar, J., Camu, W., Raoul, C., & Lumbroso, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163858 · Cited by 86
Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid
van Neerven, S., Nemes, A., Imholz, P., Regen, T., Denecke, B., Johann, S., Beyer, C., Hanisch, U., & Mey, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.005 · Cited by 78
Chupani, L., Zusková, E., Niksirat, H., Panáček, A., Lünsmann, V., Haange, S., von Bergen�, M., & Jehmlich, N. (2016) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2016.11.154 · Cited by 77
The roles of liver X receptor α in inflammation and inflammation‐associated diseases
Zhao, L., Lei, W., Deng, C., Wu, Z. B., Sun, M., Jin, Z., Song, Y., Yang, Z. P., Jiang, S., Shen, M., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30204 · Cited by 75
TLR2 Expression in Astrocytes Is Induced by TNF-α- and NF-κB-Dependent Pathways
Phulwani, N. K., Esen, N., Syed, M., & Kielian, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3841 · Cited by 73
Aye, I. L. M. H., Waddell, B. J., Mark, P. J., & Keelan, J. A. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas001 · Cited by 75
Wu, C., Chen, C.-C., Lai, C.-Y., Hung, T., Lin, C.-C., Chao, M., & Chen, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0524-8 · Cited by 72
The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis
Fragoso, Y. D., Stoney, P. N., & McCaffery, P. J. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0148-4 · Cited by 61
Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?
Pineda‐Torra, I., Siddique, S., Waddington, K. E., Farrell, R. A., & Jury, E. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639757 · Cited by 63
Aoyama, A., Endo‐Umeda, K., Kishida, K., Ohgane, K., Noguchi‐Yachide, T., Aoyama, H., Ishikawa, M., Miyachi, H., Makishima, M., & Hashimoto, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002394 · Cited by 60
Duan, H., Du, C., Shi, Y., Ren, Y., wu, H., Yao, F., Wei, J., Hou, Y., & Wu, M. T. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s90201 · Cited by 53
Endo‐Umeda, K., Nakashima, H., Komine‐Aizawa, S., Umeda, N., Seki, S., & Makishima, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-27615-7 · Cited by 55
Kane, C. J. M., & Drew, P. D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0416-171r · Cited by 54
Self-citationDuc, D., Vigne, S., & Pot, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184522 · Cited by 52
Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function
Wouters, E., de Wit, N. M., Vanmol, J., van der Pol, S. M. A., Hof, B. V. H., Sommer, D., Loix, M., Geerts, D., Gustafsson, J. A., Steffensen, K. R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01811 · Cited by 50
Zhang, X.-K., Su, Y., Chen, L., Chen, F., Liu, J., & Zhou, H. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.109 · Cited by 48
Molecular mechanisms involved in obesity-associated insulin resistance: Therapeutical approach
Fernández‐Veledo, S., Nieto-Vázquez, I., Vila‐Bedmar, R., García‐Guerra, L., Alonso-Chamorro, M., & Lorenzo, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903164330 · Cited by 48
Role for Parasite Genetic Diversity in Differential Host Responses toTrypanosoma bruceiInfection
Morrison, L. J., Mclellan, S. D., Sweeney, L., Chan, C. N., MacLeod, A., Tait, A., & Turner, C. M. R. (2010) · Infection and Immunity · doi:10.1128/iai.00943-09 · Cited by 50
MicroRNA-155 Promotes Heat Stress-Induced Inflammation via Targeting Liver X Receptor α in Microglia
Li, P., Wang, G., Zhang, X., He, G., Luo, X. G., Yang, J., Luo, Z., Shen, T., & Yang, X. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00012 · Cited by 47
Inflammatory chemokine release of astrocytes in vitro is reduced by all‐trans retinoic acid
van Neerven, S., Regen, T., Wolf, D., Nemes, A., Johann, S., Beyer, C., Hanisch, U., & Mey, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06867.x · Cited by 47
APOEgenotype-dependent modulation of astrocyte chemokine CCL3 production
Cudaback, E., Yang, Y. J., Montine, T. J., & Keene, C. D. (2014) · Glia · doi:10.1002/glia.22732 · Cited by 47
Jin, N., Gao, L., Fan, X., & Xu, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9960-9 · Cited by 47
Phytosterols: Targeting Neuroinflammation in Neurodegeneration
Dash, R., Mitra, S., Ali, M. C., Oktaviani, D. F., Hannan, M. A., Choi, S. M., & Moon, I. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200628022812 · Cited by 47
Fernández‐Veledo, S., Nieto-Vázquez, I., de Castro, J., Ramos, P., Brüderlein, S., Möller, P., & Lorenzo, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2472 · Cited by 45
Bigini, P., Steffensen, K. R., Ferrario, A., Diomede, L., Ferrara, G. B., Barbera, S., Salzano, S., Fumagalli, E. R., Ghezzi, P., Mennini, T., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181df20e1 · Cited by 47
Mechanisms for Reducing Neuropathic Pain
Kuffler, D. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01757-9 · Cited by 43
Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
Saijo, K., Crotti, A., & Glass, C. K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06002-5 · Cited by 42
Liver X receptors, nervous system, and lipid metabolism.
Cermenati, G., Brioschi, E., Abbiati, F., Melcangi, R. C., Caruso, D., & Mitro, N. (2013) · PubMed · doi:10.3275/8941 · Cited by 42
LXR agonism for CNS diseases: promises and challenges
Zhang, R., Wuerch, E. C., Yong, V. W., & Xue, M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03056-0 · Cited by 40
Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis
Tietz, A. K., Angstwurm, K., Baumgartner, T. R., Doppler, K., Eisenhut, K., Elišák, M., Franke, A., Golombeck, K. S., Handreka, R., Kaufmann, M., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001085 · Cited by 35
Liver X Receptors, Atherosclerosis and Inflammation
Michael, D. R., Ashlin, T. G., Buckley, M. L., & Ramji, D. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0239-y · Cited by 35
Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Secor McVoy, J. R., Oughli, H. A., & Oh, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0247-2 · Cited by 34
PPARγ agonists: Potential treatments for exudative age-related macular degeneration
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.09.008 · Cited by 29
Wang, Y., Wen, W., Yi, Y., Zhang, Z., Lubet, R. A., & You, M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0221 · Cited by 30
Wang, W., Nakashima, K., Hirai, T., & Inoue, M. (2019) · Journal of Natural Medicines · doi:10.1007/s11418-018-01277-1 · Cited by 24
Sevastou, I. G., Pryce, G., Baker, D., & Selwood, D. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157754 · Cited by 27
Liver X Receptor Regulation of Glial Cell Functions in the CNS
Song, X., Wu, W., Warner, M. N., & Gustafsson, J.-Α. (2022) · Biomedicines · doi:10.3390/biomedicines10092165 · Cited by 28
Retinal and optic nerve degeneration in liver X receptor β knockout mice
Song, X., Wu, W.-F., Gabbi, C., Dai, Y.-B., So, M., Chaurasiya, S., Wang, L., Warner, M. N., & Gustafsson, J.-Α. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904719116 · Cited by 27
Kim, J. H., Yu, K. S., Jeong, J. H., Lee, N. S., Lee, J., Jeong, Y. G., Yoo, Y. C., & Han, S. Y. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1178-x · Cited by 26
Yang, Y., Tang, Y., Xing, Y. T., Zhao, M., Bao, X., Sun, D., Tang, X., Wu, Y., Xu, H., & Fan, X. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8510-y · Cited by 25
Inflammation at the blood-brain barrier: The role of liver X receptors
de Wit, N. M., Vanmol, J., Kamermans, A., Hendriks, J. J. A., & de Vries, H. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.015 · Cited by 27
Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis
Mulder, J. (2009) · Frontiers in bioscience · doi:10.2741/3400 · Cited by 24
Liver X receptors regulate cerebrospinal fluid production
Dai, Y.-B., Wu, W.-F., Huang, B., Miao, Y.-F., Nadarshina, S., Warner, M., & Gustafsson, J.-Å. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.133 · Cited by 22
Li, L., Zhang, Q., Jiahe, P., Jiang, C., Zhang, Y., Shen, L., Dong, J., Wang, Y., & Jiang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.056 · Cited by 22
Bogie, J. F. J., Vanmierlo, T., Vanmol, J., Timmermans, S., Mailleux, J., Nelissen, K., Wijnands, E., Wouters, K., Stinissen, P., Gustafsson, J.-Α., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102723 · Cited by 20
Kugita, M., Nishii, K., Morita, M., Yoshihara, D., Kowa, H., Yamada, K., Yamaguchi, T., Wallace, D. P., Calvet, J. P., Kurahashi, H., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00470.2010 · Cited by 20
Interaction between CD14 and LXRβ genes modulates Alzheimer's disease risk
Rodríguez‐Rodríguez, E., Sánchez‐Juan, P., Mateo, I., Infante, J., Sánchez‐Quintana, C., García‐Gorostiaga, I., Berciano, J., & Combarros, O. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.001 · Cited by 20
Scholz, H., Lund, T., Dahle, M. K., Collins, J. L., Korsgren, O., Wang, J. E., & Foss, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1366-z · Cited by 18
Saba, E., Irfan, M., Jeong, D., Ameer, K., Lee, Y. Y., Park, C.-K., Hong, S.-B., & Rhee, M. H. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.06.005 · Cited by 15
Mouzat, K., Raoul, C., Polge, A. S., Kantar, J., Camu, W., & Lumbroso, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2330-y · Cited by 15
Ramaswami, G., Yuva-Aydemir, Y., Akerberg, B. N., Matthews, B. J., Williams, J., Golczer, G., Huang, J., Abdullatif, A. A., Huh, D., Burkly, L. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52311-0 · Cited by 18
Nuclear receptors of NR1 and NR4 subfamilies in the regulation of microglial functions and pathology
Katsuki, H. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.766 · Cited by 14
Expression of retinoid X receptor beta is induced in astrocytes during corpus callosum demyelination
König, R., Stillfried, M., Aperdannier, P., Clarner, T., Beyer, C., Kipp, M., & Mey, J. (2012) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.01.002 · Cited by 13
Liver X receptors: A therapeutic target in demyelinating disorders
Richartz, J., Yam, S. C., Zhan, N., Schepers, M., Tiane, A., Mulder, M. T., Wens, I., & Vanmierlo, T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107861 · Cited by 12
Fandel, D., Wasmuht, D., Ávila-Martín, G., Taylor, J., Galán-Arriero, I., & Mey, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.022 · Cited by 12
Activation of FXR pathway does not alter glial cell function
Albrecht, S., Fleck, A.-K., Kirchberg, I. E., Hucke, S., Liebmann, M., Klotz, L., & Kuhlmann, T. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0833-6 · Cited by 11
Choudhary, M., & Malek, G. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_7 · Cited by 11
Tice, C. M., Noto, P. B., Fan, K. Y., Zhao, W. L., Lotesta, S. D., Dong, C., Marcus, A. P., Zheng, Y., Chen, G., Wu, Z., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.089 · Cited by 12
Ban, S. Y., Nam, Y., Do, T. T., Kim, B., Shin, S. J., Nguyen, M. T. T., Kim, J., Moon, M., & Park, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117895 · Cited by 11
Role of liver X receptor in multiple sclerosis: A long furtive life behind a barrier
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E., Fawzy, M. N., Alruwaili, M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111333 · Cited by 10
Nagulapalli, M., Rajesh, H., Berwal, P., Phukan, S., & Balaji, V. N. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00620.x · Cited by 10
Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity
Eskandari, M., & Mellati, A. A. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.050 · Cited by 9
Bánáti, D., Hellmann‐Regen, J., Mack, I., Young, H. A., Benton, D., Eggersdorfer, M. L., Rohn, S., Dulińska-Litewka, J., Krężel, W., & Rühl, R. (2024) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000808 · Cited by 7
Mohammadi, E., Ghaedi, K., Esmailie, A., & Rahgozar, S. (2013) · Journal of Spinal Cord Medicine · doi:10.1179/2045772312y.0000000032 · Cited by 7
Chances and Challenges of RXRγ Targeting for Regenerative Multiple Sclerosis Treatment
Merk, D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.163 · Cited by 7
Zhang, Q., Mao, J.-D., Wang, M., Chen, H., Wang, Q.-F., Zhang, K., Yang, L., Ma, X., Wang, C., & Wu, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.050 · Cited by 6
Lv, K., Luo, Y., Liu, T., Xia, M., Gong, H., Zhang, D., Chen, X., Jiang, X., Liu, Y., Liu, J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410698122 · Cited by 6
Shen, H., Zhou, X. E., Bai, A., & Ren, X. (2013) · Crustaceana · doi:10.1163/15685403-00003248 · Cited by 6
Salman, E. D., He, D., Runge‐Morris, M., Kocarek, T. A., & Falany, C. N. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.010 · Cited by 6
Liu, P., He, S., Gao, J., Li, J., Fan, X., & Xiao, Y. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.923295 · Cited by 6
Li, J., Zhu, P., Li, Y., Xiao, K., Tang, J., Liang, X., Luo, Y., Wang, J., Deng, Y., Jiang, L. H., et al. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25380 · Cited by 7
Macrophage Nuclear Receptor Corepressor 1 Deficiency Protects Against Ischemic Stroke in Mice
Shao, S., Chen, Y., Du, L., Liu, Y., Zhu, H., Zhou, L.-J., Liu, T., Lin, W.-Z., Yu, F., Ma, X., et al. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10187-9 · Cited by 5
Birkle, T. J. Y., Willems, H. M. G., Skidmore, J., & Brown, G. C. (2024) · iScience · doi:10.1016/j.isci.2024.109454 · Cited by 4
Nuclear Receptor Control of Myeloid Cell Responses - Implications for CNS Autoimmunity
Wiendl, S. H. H. (2013) · Rheumatology Current Research · doi:10.4172/2161-1149.1000124 · Cited by 4
Jakimovski, D., Zivadinov, R., Pelizzari, L., Dunne-Jaffe, C., Browne, R. W., Bergsland, N., Dwyer, M. G., Weinstock‐Guttman, B., & Ramanathan, M. K. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103906 · Cited by 3
Ju, H.-H., Lee, J., Kim, S.-K., Kim, S.-Y., Ahn, J.-H., Skiba, N. P., Rao, P. V., & Choi, J. A. (2024) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167573 · Cited by 3
Štefulj, J., Panzenboeck, U., Hof, P. R., & Šimić, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0136-z · Cited by 3
Todorovic, S. T., Milosevic, K., Milosevic, A., Janjic, M. M., Sokanovic, S. J., Savić, D. Z., & Lavrnja, I. C. (2024) · Folia Neuropathologica · doi:10.5114/fn.2024.141376 · Cited by 2
Metadata
- Authors
- Zhang-Gandhi, C. X., & Drew, P. D.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Drew, Paul D.
- ORCID
- Drew, Paul D.
- Venue
- Journal of Neuroimmunology
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 183
- Issue
- 1-2
- Pages
- 50-59
- ISSN
- 0165-5728 (ISSN-L)
- PMC
- PMC2080645
- OpenAlex
- W2034959869
- Cited by
- 117
- References
- 50
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuroimmunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS 047546, NS42860, P30NS047546, R01NS042860)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- liver X receptor agonist, retinoid X receptor agonist, microglia, astrocytes, neuroinflammation, multiple sclerosis, NF-κB signaling, nitric oxide, IL-1β, interleukin-6, MCP-1, lipopolysaccharide stimulation, IκBα degradation, anti-inflammatory activity
- MeSH terms
- Liver X Receptors, Benzenesulfonamides, Analysis of Variance, Animals, Animals, Newborn, Astrocytes, Cell Survival, Cells, Cultured, Cerebral Cortex, DNA-Binding Proteins, Dose-Response Relationship, Drug, Drug Interactions, Fluorocarbons, Gene Expression Regulation, Hydrocarbons, Fluorinated, Lipopolysaccharides, Nitric Oxide, Nitroprusside, Sulfonamides, Cytokines, Microglia, Receptors, Cytoplasmic and Nuclear, Retinoid X Receptors, Mice, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review